CANNABIDIOL AS A POTENTIAL TREATMENT FOR ANXIETY DISORDERS
Esther M. Blessing, Maria M. Steenkamp, Jorge Manzanares & Charles R. Marmar
Neurotherapeutics. 2015 Nov; 12(4): 825-836.
Published online 2015 Sep. 4 Doi: [10.1007/s13311-015-0387-1].
This review of 49 studies assesses the use of medicinal cannabis for anxiety-related disorders. The available evidences demonstrates there is a potential benefit of cannabinoids in reducing anxiety behaviors relevant to disorders such as PTSD, GAD, PD, OCD, and SAD, with no anxiogenic effects. The authors emphasise the potential value and need for further study of CBD in the treatment of anxiety disorders.
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.